Skip to main content
. 2022 Nov 10;12:1066557. doi: 10.3389/fonc.2022.1066557

Table 3.

The top 10 journals with highest citation per paper per year in lung cancer radiotherapy from 2000 to 2022 a .

Journals Paper number Top-Paper number Top-Paper rate b Total citation Citation per paper Citation per paper per year Local citation c IF (2021)
N. Engl. J. Med. 5 5 100.00% 6269 1253.80 191.09 8423 176.08
Lancet 7 6 85.71% 3635 519.29 75.47 3070 202.73
Lancet Oncol. 29 9 31.03% 7461 257.28 41.57 4248 54.43
JAMA Oncol. 24 2 8.33% 1846 76.92 24.80 926 33.01
J. Clin. Oncol. 153 29 18.95% 24346 159.12 15.08 23597 50.72
JNCI 14 3 21.43% 2034 145.29 10.38 1815 11.82
J. Nucl. Med. 39 3 7.69% 3005 77.05 9.39 1734 11.08
Clin. Chest Med. 9 1 11.11% 933 103.67 9.36 171 4.97
Radiology 14 1 7.14% 1199 85.64 8.49 1952 29.15
Cancer Res. 29 2 6.90% 2993 103.21 7.84 4996 13.31
a

Only journals with at least five papers related to lung cancer radiotherapy were included.

b

Percentage of top- papers among all papers in a journal. The time span was from 2010 to 2019 (the publication year of the lastest top- paper).

c

Citation number in the current dataset (papers in lung cancer radiotherapy from 2000 to 2022).